Infliximab is an established therapy for some auto-immune diseases like rheumatoid arthritis, Crohns disease, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis and ulcerative colitis. In this book, the authors present current research in the study of the pharmacology, uses and limitations of infliximab. Topics discussed include the risk of infection in patients treated with infliximab; the efficacy and safety of infliximab during pregnancy and breastfeeding in women with inflammatory bowel disease; and disease activity, treatment response and drug continuation rates among patients with rheumatoid arthritis treated with infliximab.
Preface; The Risk of Infection in Patients Treated with Infliximab; Infliximab in Inflammatory Bowel Disease; Infliximab:: Up-to-Date on Indications & Warnings; Infliximab in Inflammatory Bowel Diseases:: Pharmacology, Uses & Limitations; Efficacy & Safety of Infliximab during Pregnancy & Breastfeeding in Women with Inflammatory Bowel Disease; Anti--TNFs for Postoperative Recurrence of Crohns Disease:: The State of the Art.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.